Skip to main content Skip to main navigation menu Skip to site footer
Research Articles
Published: 2021-06-28

Mental disorders in hospital COVID-19 patients

Department of Psychosomatic Medicine and Psychotherapy, Bogomolets National Medical University
Bogomolets National Medical University
Bohomolets National Medical University
Kyiv Railway Clinical Hospital
Kyiv Railway Clinical Hospital
Mental disorders depression anxiety Acute phase Covid-19 Inpatients Sleep disturbances GAD-7 PHQ-9


Background. The peculiarity of the COVID-19 pandemic is not only that it causes severe somatic disorders, the main of which is acute viral pneumonia, but also psychological stress and symptoms of mental disorders such as depression, anxiety and sleep disorders. As well as other infectious diseases, COVID-19 also causes panic in society and psychological distress.

Objective. To evaluate mental disorders in hospital patients in the acute phase of COVID-19.

Materials and methods. The study group included 90 patients with moderate to severe viral pneumonia COVID-19. The average age of the subjects was 58.64 ± 11.39 years. 32% of respondents (29 people) had secondary education, 61% of respondents (61 people) had higher education. 51% of the subjects were male (46 people), 49% - female (44 people). As part of psychiatric screening, PHQ-9 depression and GAD-7 anxiety questionnaires were used to study psychopathological symptoms on admission to the hospital.
Results. The study found that symptoms of anxiety and depression were common in inpatients with COVID-19. 56% of patients hospitalized with COVID-19 pneumonia had depressive symptoms of varying severity (from mild to extremely severe) and 64% had anxiety symptoms (from mild to severe).  Depression was more common than anxiety in patients after COVID-19.  In addition, there was a clear trend toward a much more severe course of depressive and, to a lesser extent, anxiety in patients over 65 years of age, making elderly patients at risk for severe emotional states after COVID-19. Therefore, this group needs increased attention from medical staff during the diagnosis and treatment of mental disorders.

Full-text of the article is available for this locale: Українська.


  1. Ministry of Health of Ukraine. Operational information on the spread and prevention of COVID-19. Kyiv: MOZ; 2021. URL:
  2. Bao Y, Sun Y, Meng S, Shi J, Lu L. 2019-nCoV epidemic: address mental health care to empower society. Lancet. 2020;395(10224):e37-e38. DOI:
  3. Zhang C, Yang L, Liu S, et al. Survey of Insomnia and Related Social Psychological Factors Among Medical Staff Involved in the 2019 Novel Coronavirus Disease Outbreak. Front Psychiatry. 2020;11:306. DOI:
  4. Salari N, Hosseinian-Far A, Jalali R, et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Global Health. 2020;16(1):576. DOI:
  5. Hu Y, Chen Y, Zheng Y, et al. Factors related to mental health of inpatients with COVID-19 in Wuhan, China. Brain Behav Immun. 2020;89:587-593. DOI:
  6. Wańkowicz P, Szylińska A, Rotter I. The Impact of the COVID-19 Pandemic on Psychological Health and Insomnia among People with Chronic Diseases. Journal of Clinical Medicine. 2021; 10(6):1206.
  7. Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. 2021 Jan;8(1):e1]. Lancet Psychiatry. 2021;8(2):130-140. DOI:
  8. Fornili M, Petri D, Berrocal C, et al. Psychological distress in the academic population and its association with socio-demographic and lifestyle characteristics during COVID-19 pandemic lockdown: Results from a large multicenter Italian study. PLoS One. 2021;16(3):e0248370. DOI:
  9. Verma S, Mishra A. Depression, anxiety, and stress and socio-demographic correlates among general Indian public during COVID-19. Int J Soc Psychiatry. 2020;66(8):756-762. DOI:
  10. Dai LL, Wang X, Jiang TC, et al. Anxiety and depressive symptoms among COVID-19 patients in Jianghan Fangcang Shelter Hospital in Wuhan, China. PLoS One. 2020;15(8):e0238416. DOI:
  11. Lee AM, Wong JG, McAlonan GM, et al. Stress and Psychological Distress among SARS Survivors 1 Year after the Outbreak. The Canadian Journal of Psychiatry. 2007;52(4):233-240. doi:10.1177/070674370705200405
  12. Deng J, Zhou F, Hou W, et al. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann N Y Acad Sci. 2021;1486(1):90-111. DOI:
  13. Hao F, Tan W, Jiang L, et al. Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry. Brain Behav Immun. 2020;87:100-106. DOI:
  14. Sun Q, Qin Q, Basta M, Chen B, Li Y. Psychological reactions and insomnia in adults with mental health disorders during the COVID-19 outbreak. BMC Psychiatry. 2021;21(1):19. DOI:
  15. Li Y, Gu S, Wang Z, et al. Relationship Between Stressful Life Events and Sleep Quality: Rumination as a Mediator and Resilience as a Moderator. Front Psychiatry. 2019;10:348. DOI:
  16. Dubuque CR, Elliott WJ, May R. Sleep quality, stress, depressive symptoms, and body-mass index as predictors of elevated blood pressures in college students. Journal of the American Society of Hypertension. 2014;8(4):e122. DOI:
  17. Sheng B, Cheng SK, Lau KK, Li HL, Chan EL. The effects of disease severity, use of corticosteroids and social factors on neuropsychiatric complaints in severe acute respiratory syndrome (SARS) patients at acute and convalescent phases. Eur Psychiatry. 2005;20(3):236-42. DOI:
  18. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-481. DOI:
  19. Lam MH, Wing YK, Yu MW, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169(22):2142-2147. DOI:
  20. Park HY, Jung J, Park HY, et al. Psychological Consequences of Survivors of COVID-19 Pneumonia 1 Month after Discharge. J Korean Med Sci. 2020;35(47):e409. DOI:
  21. Alonso-Lana S, Marquié M, Ruiz A, Boada M. Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia. Front Aging Neurosci. 2020;12:588872. DOI:
  22. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101-2107. DOI:
  23. Polikandrioti M, Goudevenos J, Michalis LK, et al. Factors associated with depression and anxiety of hospitalized patients with heart failure. Hellenic J Cardiol. 2015;56(1):26-35.
  24. Asanova A, Khaustova O. Typical difficult situations in doctor-patient interactions. PMGP. 2018;3(3):e0303125. DOI:
  25. Kong X, Kong F, Zheng K, et al. Effect of Psychological-Behavioral Intervention on the Depression and Anxiety of COVID-19 Patients. Front Psychiatry. 2020;11:586355. DOI:
  26. Hwang TJ, Rabheru K, Peisah C, Reichman W, Ikeda M. Loneliness and social isolation during the COVID-19 pandemic. Int Psychogeriatr. 2020;32(10):1217-1220. DOI:
  27. Dai LL, Wang X, Jiang TC, et al. Anxiety and depressive symptoms among COVID-19 patients in Jianghan Fangcang Shelter Hospital in Wuhan, China. PLoS One. 2020;15(8):e0238416. DOI:
  28. Khaustova O, Chaban O. Pharmacotherapy of Mental Disorders Associated with COVID-19. Psychiatry, Psychotherapy and Clinical Psychology. 2021;12(1):85-105. URL:
  29. Asanova A. Personalized approach in the treatment of mental disorders: Long-term prospects for the use of low doses of psychotropic drugs. PMGP. 2020;5(2): e0502239. URL:
  30. Chaban O, Khaustova O. Mental health during the COVID-19 pandemic (features of psychological crisis, anxiety, fear and anxiety disorders). NEIRONEWS. 2020;3(114):26-36.
  31. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613. DOI:
  32. Löwe B, Decker O, Müller S, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008;46(3):266-274. DOI:

How to Cite

Асанова А, Хаустова О, Чабан О, Прохорова О, Кузьмицький M, Тимощук Є, Авраменко О. Mental disorders in hospital COVID-19 patients . PMGP [Internet]. 2021Jun.28 [cited 2022Jan.22];6(2):e0602304. Available from: